An experimental analysis of causative factors and protective methods in carotid artery rupture.
D000818:Animals; D001414:Bacitracin / Q000627:therapeutic use; D001424:Bacterial Infections / Q000517:prevention & control; D002339:Carotid Arteries / Q000473:pathology; D020212:Carotid Artery Injuries; D004195:Disease Models, Animal; D004285:Dogs; D005402:Fistula / Q000503:physiopathology; D006257:Head / Q000601:surgery*; D009132:Muscles / Q000601:surgery; D009333:Neck / Q000601:surgery*; D010608:Pharyngeal Diseases / Q000503:physiopathology; D011113:Polymyxins / Q000627:therapeutic use; D011183:Postoperative Complications; D011482:Protective Devices; D012421:Rupture / Q000209:etiology* / Q000401:mortality / Q000517:prevention & control; D012463:Saliva; D012540:Scapula / Q000601:surgery; D012871:Skin Diseases / Q000503:physiopathology; D016038:Skin Transplantation; D013194:Staining and Labeling; D013514:Surgical Procedures, Operative / Q000009:adverse effects; D014182:Transplantation, Autologous; D014651:Vasa Vasorum / Q000601:surgery
D011113:Polymyxins; D001414:Bacitracin